Burr DB - Search Results

1

Increased strontium uptake in trabecular bone of ovariectomized calcium-deficient rats treated with strontium ranelate or strontium chloride.

Pemmer B, Hofstaetter JG, Meirer F, Smolek S, Wobrauschek P, Simon R, Fuchs RK, Allen MR, Condon KW, Reinwald S, Phipps RJ, Burr DB, Paschalis EP, Klaushofer K, Streli C, Roschger P. Pemmer B, et al. Among authors: burr db. J Synchrotron Radiat. 2011 Nov;18(Pt 6):835-41. doi: 10.1107/S090904951103038X. Epub 2011 Sep 15. J Synchrotron Radiat. 2011. PMID: 21997907

2

Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats.

Fuchs RK, Phipps RJ, Burr DB. Fuchs RK, et al. Among authors: burr db. J Bone Miner Res. 2008 Oct;23(10):1689-97. doi: 10.1359/jbmr.080501. J Bone Miner Res. 2008. PMID: 18466070 Free PMC article.

3

Strontium ranelate does not stimulate bone formation in ovariectomized rats.

Fuchs RK, Allen MR, Condon KW, Reinwald S, Miller LM, McClenathan D, Keck B, Phipps RJ, Burr DB. Fuchs RK, et al. Among authors: burr db. Osteoporos Int. 2008 Sep;19(9):1331-41. doi: 10.1007/s00198-008-0602-6. Epub 2008 Apr 3. Osteoporos Int. 2008. PMID: 18385919

4

Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment.

Allen MR, Burr DB. Allen MR, et al. Among authors: burr db. J Bone Miner Res. 2007 Nov;22(11):1759-65. doi: 10.1359/jbmr.070720. J Bone Miner Res. 2007. PMID: 17663638 Free article.

5

Bone quality in an ovariectomized monkey animal model treated with two doses of teriparatide for either 18 months, or 12 months followed by withdrawal for 6 months.

Paschalis EP, Gamsjaeger S, Burr DB. Paschalis EP, et al. Among authors: burr db. Bone. 2022 May;158:116366. doi: 10.1016/j.bone.2022.116366. Epub 2022 Feb 12. Bone. 2022. PMID: 35167989

6

Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate.

Allen MR, Turek JJ, Phipps RJ, Burr DB. Allen MR, et al. Among authors: burr db. Bone. 2011 Jul;49(1):128-32. doi: 10.1016/j.bone.2010.07.011. Epub 2010 Jul 15. Bone. 2011. PMID: 20637914

7

Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment.

Allen MR, Burr DB. Allen MR, et al. Among authors: burr db. J Oral Maxillofac Surg. 2008 May;66(5):987-94. doi: 10.1016/j.joms.2008.01.038. J Oral Maxillofac Surg. 2008. PMID: 18423290 Free PMC article.

8

Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.

Feher A, Koivunemi A, Koivunemi M, Fuchs RK, Burr DB, Phipps RJ, Reinwald S, Allen MR. Feher A, et al. Among authors: burr db. Bone. 2010 Jan;46(1):203-7. doi: 10.1016/j.bone.2009.10.023. Epub 2009 Oct 24. Bone. 2010. PMID: 19857619

9

Low bone turnover and microdamage? How and where to assess it?

Burr DB, Allen MR. Burr DB, et al. J Bone Miner Res. 2008 Jul;23(7):1150-1; author reply 1152-3. doi: 10.1359/jbmr.080307. J Bone Miner Res. 2008. PMID: 18348687 Free article. No abstract available.

10

Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment.

Allen MR, Reinwald S, Burr DB. Allen MR, et al. Among authors: burr db. Calcif Tissue Int. 2008 May;82(5):354-60. doi: 10.1007/s00223-008-9131-8. Epub 2008 May 8. Calcif Tissue Int. 2008. PMID: 18463913 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters